Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 4/20 | 0.85 |
| ▸ | PRKCG | P05129 | 4/20 | 0.85 |
| ▸ | PRKCB | P05771 | 4/20 | 0.85 |
| ▸ | PRKCA | P17252 | 4/20 | 0.85 |
| ▸ | PRKCH | P24723 | 4/20 | 0.85 |
| ▸ | PRKCI | P41743 | 4/20 | 0.85 |
| ▸ | PRKCE | Q02156 | 4/20 | 0.85 |
| ▸ | PRKCQ | Q04759 | 4/20 | 0.85 |
| ▸ | PRKCZ | Q05513 | 4/20 | 0.85 |
| ▸ | PRKCD | Q05655 | 4/20 | 0.85 |
| ▸ | PRKD1 | Q15139 | 4/20 | 0.85 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.73 |
| ▸ | SNCA | P37840 | 4/20 | 0.71 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.71 |
| ▸ | PKM | P14618 | 2/20 | 0.71 |
| ▸ | BACE1 | P56817 | 2/20 | 0.71 |
| ▸ | BCL2 | P10415 | 2/20 | 0.71 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.71 |
| ▸ | PGD | P52209 | 2/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22295330 | 1.00 | PRKD3 (0.85) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL30538719 | 1.00 | PRKD3 (0.85) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL29437883 | 1.00 | PRKD3 (0.85) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL30834898 | 1.00 | PRKD3 (0.85) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL25182577 | 0.99 | PRKD3 (0.84) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL22295316 | 0.99 | PRKD3 (0.85) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL22821108 | 0.99 | PRKD3 (0.85) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL13934797 | 0.99 | PRKD3 (0.84) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL13934793 | 0.99 | PRKD3 (0.84) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL13934799 | 0.94 | PTGS2 (0.82) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2024073025-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | PRKD3 698/4885PRKCG 194/4885PRKCB 272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.